These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29330172)

  • 1. Origins of tobacco harm reduction in the UK: the 'Product Modification Programme' (1972-1991).
    Elias J; Ling PM
    Tob Control; 2018 Jul; 27(e1):e12-e18. PubMed ID: 29330172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issue network versus producer network? ASH, the Tobacco Products Research Trust and UK smoking policy.
    Berridge V
    Clio Med; 2005; 75():101-24. PubMed ID: 16212728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette".
    Parascandola M
    Nicotine Tob Res; 2005 Oct; 7(5):779-89. PubMed ID: 16191749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the emergence of the tobacco industry's use of the term tobacco harm reduction in order to inform public health policy.
    Peeters S; Gilmore AB
    Tob Control; 2015 Mar; 24(2):182-9. PubMed ID: 24457543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Origins in the USA in the 1980s of the warning that smokeless tobacco is not a safe alternative to cigarettes: a historical, documents-based assessment with implications for comparative warnings on less harmful tobacco/nicotine products.
    Kozlowski LT
    Harm Reduct J; 2018 Apr; 15(1):21. PubMed ID: 29661189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.
    Tan CE; Kyriss T; Glantz SA
    PLoS Med; 2013; 10(5):e1001450. PubMed ID: 23723740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco control in Nepal during a time of government turmoil (1960-2006).
    Bhatta D; Crosbie E; Bialous S; Glantz S
    Tob Control; 2020 Sep; 29(5):548-555. PubMed ID: 31363061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Australian tar derby: the origins and fate of a low tar harm reduction programme.
    King W; Carter SM; Borland R; Chapman S; Gray N
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii61-70. PubMed ID: 14645950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The place for harm reduction and product regulation in UK tobacco control policy.
    Gilmore AB; Britton J; Arnott D; Ashcroft R; Jarvis MJ
    J Public Health (Oxf); 2009 Mar; 31(1):3-10. PubMed ID: 19109341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the Origins of the Electronic Cigarette: British American Tobacco's Project Ariel (1962-1967).
    Risi S
    Am J Public Health; 2017 Jul; 107(7):1060-1067. PubMed ID: 28520481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Science and policy: the case of postwar British smoking policy.
    Berridge V
    Clio Med; 1998; 46():143-62; discussion 163. PubMed ID: 9607153
    [No Abstract]   [Full Text] [Related]  

  • 13. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction.
    Kozlowski LT; Abrams DB
    BMC Public Health; 2016 May; 16():432. PubMed ID: 27221096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seeking out 'easy targets'? Tobacco companies, health inequalities and public policy.
    Clifford D; Hill S; Collin J
    Tob Control; 2014 Nov; 23(6):479-83. PubMed ID: 23832052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policy and health implications of using the U.S. Food and Drug Administration product design approach in reducing tobacco product risk.
    Givel M
    Curr Drug Abuse Rev; 2008 Jun; 1(2):135-41. PubMed ID: 19630712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [History of Brazil's tobacco control policy from 1986 to 2016].
    Portes LH; Machado CV; Turci SRB
    Cad Saude Publica; 2018 Feb; 34(2):e00017317. PubMed ID: 29489940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a comprehensive policy on nicotine delivery products and harm reduction.
    Solyst J
    Food Drug Law J; 2012; 67(4):393-404, i. PubMed ID: 24640613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. We need to regulate the contents and construction of cigarettes to discourage initiation and facilitate cessation.
    King B
    Tob Control; 2015 Dec; 24(e4):e232. PubMed ID: 26660075
    [No Abstract]   [Full Text] [Related]  

  • 19. Harm reduction in U.S. tobacco control: Constructions in textual news media.
    Eversman MH
    Int J Drug Policy; 2015 Jun; 26(6):575-82. PubMed ID: 25727451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intractable cigarette 'filter problem'.
    Harris B
    Tob Control; 2011 May; 20 Suppl 1(Suppl_1):i10-6. PubMed ID: 21504917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.